Wuhan Therasource Biosciences Inc;Shanghai Union Biopharm Co., Ltd.
发明人:
申请号：
EP13794561.4
公开号：
EP2853543A8
申请日:
2013.05.22
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention belongs to the field of biopharmaceutics. Disclosed is an anti-BLyS antibody. The anti-BLyS antibody specifically targets BLyS, can combine with a B lymphocyte stimulating factor, and can inhibit the combination of the B lymphocyte stimulating factor with the receptor BR3-Fc thereof. Also provided are uses of the anti-BLyS antibody in the manufacture of a medicament for preventing and/or treating diseases caused by the excessive proliferation of B cells such as systemic lupus erythematorsus.
